India · Series A startup

Who invested in Dexetra

2 rounds we have observed, with the 4 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Telecoms

Funding summaryUpdated 26 Oct 2026

$1.2Mraised across 2 rounds since 2011, from 2 sources

$200KSeed$1.0MSeries A
Latest round
Series A, $1.0MJan 2013
Step-upi
5×
Investors
4
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20122013
$200KSeed$1.0MSeries A
First round
Seed, $200K
Oct 2011
Biggest round
$1.0M
Series A · Jan 2013
Between rounds
16 months
from the last two

The rounds

  1. Jan 2013
  2. Oct 2011
    Seed$200K1 new

    Reported by blog.dexetra.com

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

Sequoia CapitalVC firm1round
Qualcomm VenturesCorporate VC1round
M VenturesCorporate VC1round
One97 CommunicationsCorporate VC1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Dexetra

Who invested in Dexetra?

Dexetra's investors include Sequoia Capital, Qualcomm Ventures, M Ventures and One97 Communications.

How much has Dexetra raised?

Dexetra has raised $1.2M across 2 rounds since 2011.

When did Dexetra last raise?

Dexetra's most recent round was a Series A of $1.0M in Jan 2013.

What was Dexetra's biggest round?

Its most recent round, $1.0M in Jan 2013, is also its largest on record.

Who backed Dexetra first?

Dexetra's first round on record, in Oct 2011, was backed by One97 Communications.

What stage is Dexetra at?

Dexetra's latest named round is a Series A, in Jan 2013.

Where is Dexetra based?

Dexetra is based in India.

Companies like Dexetra

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.